A RATER-BLINDED, RANDOMIZED, COMPARATIVE STUDY OF ARIPIPRAZOLE VERSUS BLONANSERIN IN JAPANESE PATIENTS WITH SCHIZOPHRENIA

被引：0
|
作者：
Mukai, Tomohiko [1 ]
机构：
[1] Fujita Hlth Univ, Dept Psychiat, Sch Med, Toyoake, Aichi, Japan
来源：
SCHIZOPHRENIA RESEARCH | 2014年 / 153卷
关键词：
D O I：
10.1016/S0920-9964(14)70783-2
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
M233
引用
收藏
页码：S274 / S275
页数：2
相关论文
共 50 条
  • [1] Blonanserin versus aripiprazole for treatment of Japanese schizophrenia patients: a randomized control trial
    Hori, H.
    Asuka, K.
    Kiyokazu, A.
    Reiji, Y.
    Jun, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S510 - S511
  • [2] Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study
    Han, Changsu
    Wang, Sheng-Min
    Kwak, Kyung-Phil
    Won, Wang-Yeon
    Lee, HwaYoung
    Chang, Chia Ming
    Tang, Tze Chun
    Pae, Chi-Un
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 66-67 : 84 - 94
  • [3] A randomized comparative study of perospirone and aripiprazole for Japanese schizophrenia patients
    Takekita, Y.
    Kato, M.
    Sakai, S.
    Suwa, A.
    Wakeno, M.
    Okugawa, G.
    Kinoshita, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 106 - 107
  • [4] A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia
    Li, H.
    Rui, Q.
    Ning, X.
    Xu, H.
    Gu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 167 - 167
  • [5] A RANDOMIZED AND RATER-BLINDED STUDY OF THE EFFECT OF IFENPRODILON ALCOHOL REUSE IN PATIENTS WITH ALCOHOL DEPENDENCE
    Sugaya, N.
    Ogai, Y.
    Aikawa, Y.
    Yumoto, Y.
    Takahama, M.
    Tanaka, M.
    Haraguchi, A.
    Umeno, M.
    Ikeda, K.
    ALCOHOL AND ALCOHOLISM, 2014, 49
  • [6] Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: Interim results of a randomised, rater-blinded study
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S350 - S351
  • [7] Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: Interim results of a randomised, rater-blinded study
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 150 - 150
  • [8] Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    EUROPEAN PSYCHIATRY, 2004, 19 : 172S - 172S
  • [9] Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
    Lee, Seung-Hoon
    Jeon, Sang Won
    Shin, Cheolmin
    Pae, Chi-Un
    Patkar, Ashwin A.
    Masand, Prakash S.
    An, Hyonggin
    Han, Changsu
    PSYCHIATRY INVESTIGATION, 2022, 19 (04) : 268 - 280
  • [10] Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
    Woo, Young Sup
    McIntyre, Roger S.
    Kim, Jung-Bum
    Lee, Min-Soo
    Kim, Jae-Min
    Yim, Hyeon Woo
    Jun, Tae-Youn
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (04) : 391 - 401
12345